PeptiDream Inc (PPTDF)
12.80
-0.31
(-2.38%)
USD |
OTCM |
May 06, 16:00
PeptiDream Total Assets (Quarterly): 492.57M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 492.57M |
| September 30, 2023 | 442.50M |
| June 30, 2023 | 398.51M |
| March 31, 2023 | 448.62M |
| December 31, 2022 | 487.10M |
| September 30, 2022 | 354.81M |
| June 30, 2022 | 379.93M |
| March 31, 2022 | 426.89M |
| December 31, 2021 | 234.93M |
| September 30, 2021 | 249.20M |
| June 30, 2021 | 219.50M |
| March 31, 2021 | 218.96M |
| December 31, 2020 | 254.68M |
| September 30, 2020 | 180.05M |
| June 30, 2020 | 183.68M |
| March 31, 2020 | 165.32M |
| September 30, 2019 | 173.06M |
| June 30, 2019 | 185.73M |
| March 31, 2019 | 149.63M |
| December 31, 2018 | 147.06M |
| September 30, 2018 | 139.19M |
| Date | Value |
|---|---|
| June 30, 2018 | 149.31M |
| March 31, 2018 | 115.14M |
| December 31, 2017 | 109.84M |
| September 30, 2017 | 111.29M |
| June 30, 2017 | 121.65M |
| March 31, 2017 | 98.80M |
| December 31, 2016 | 96.24M |
| September 30, 2016 | 114.67M |
| June 30, 2016 | 116.30M |
| March 31, 2016 | 90.79M |
| December 31, 2015 | 62.60M |
| September 30, 2015 | 59.33M |
| June 30, 2015 | 63.07M |
| March 31, 2015 | 50.19M |
| December 31, 2014 | 50.59M |
| September 30, 2014 | 54.57M |
| June 30, 2014 | 59.15M |
| March 31, 2014 | 57.91M |
| December 31, 2013 | 57.23M |
| September 30, 2013 | 59.52M |
| June 30, 2013 | 60.17M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
165.32M
Minimum
Mar 2020
492.57M
Maximum
Dec 2023
305.33M
Average
251.94M
Median
Total Assets (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 100.85B |
| Nxera Pharma Co Ltd | 1.115B |
| Stemcell Holdings Inc | 12.03M |
| Healios KK | 107.46M |
| AnGes Inc | 204.88M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 206.45M |
| Shareholders Equity (Quarterly) | 286.12M |
| Debt to Equity Ratio | 0.5507 |
| Current Ratio | 3.159 |
| Net Debt Paydown Yield | -0.21% |